Fulcrum Capital LLC Has $5.94 Million Stock Holdings in Abbott Laboratories (NYSE:ABT)

Fulcrum Capital LLC lowered its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 4.1% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 54,522 shares of the healthcare product maker’s stock after selling 2,315 shares during the period. Abbott Laboratories comprises about 1.6% […]

Related Keywords

Andreaf Wainer ,Danielj Starks , ,Barclays ,Carmel Capital Partners ,Securities Exchange Commission ,Morgan Stanley ,Wolfe Research ,Kesler Norman Wride ,Colton Groome Financial Advisors ,Pinnacle Associates Ltd ,Jefferies Financial Group ,Abbott Laboratories ,Fulcrum Capital ,Grove Bank ,Free Report ,Capital Partners ,Groome Financial Advisors ,Kesler Norman ,Exchange Commission ,Director Daniel ,Financial Group ,Get Free Report ,Established Pharmaceutical Products ,Diagnostic Products ,Nutritional Products ,Visit Holdingschannel ,Abbott Laboratories Daily ,Nyse Abt ,Abt ,Medical ,00282410 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,